Company profile for Innovative Cellular Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Innovative Cellular Therapeutics (ICT) is a private clinical stage biotechnology company headquartered in Rockville, MD. ICT is focused on the development of cellular immunotherapies for the treatment of solid tumors. ICT’s unique CoupledCAR® technology platform is designed to overcome the common challenges of treating solid tumors. ICT has achieved promising preclinical and proof-of-concept clinical results in late-stage s...
Innovative Cellular Therapeutics (ICT) is a private clinical stage biotechnology company headquartered in Rockville, MD. ICT is focused on the development of cellular immunotherapies for the treatment of solid tumors. ICT’s unique CoupledCAR® technology platform is designed to overcome the common challenges of treating solid tumors. ICT has achieved promising preclinical and proof-of-concept clinical results in late-stage solid tumors, such as colorectal cancer and thyroid cancer. The Company has a broad pipeline of CAR-T candidates targeting additional solid tumors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1405 Research Boulevard, Suite 210, Rockville, Maryland 20850
Telephone
Telephone
+1 (240) 690 9110
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/09/19/2949259/0/en/Innovative-Cellular-Therapeutics-Announces-the-Publication-of-Groundbreaking-GCC19CART-Study-to-Treat-mCRC-in-JAMA-Oncology.html

GLOBENEWSWIRE
19 Sep 2024

https://www.globenewswire.com//news-release/2023/10/31/2770400/0/en/Innovative-Cellular-Therapeutics-ICT-Presented-Updated-Data-of-the-China-IRB-Study-of-GCC19CART-in-Metastatic-Colorectal-Cancer-at-European-Society-for-Medical-Oncology-ESMO-Congre.html

GLOBENEWSWIRE
31 Oct 2023

https://www.globenewswire.com/news-release/2023/05/24/2675160/0/en/Innovative-Cellular-Therapeutics-ICT-Presented-Data-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-26th-Annual-Meeting.html

GLOBENEWSWIRE
24 May 2023

https://www.globenewswire.com/news-release/2023/05/02/2659443/0/en/Innovative-Cellular-Therapeutics-ICT-Presented-Updated-Data-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

GLOBENEWSWIRE
02 May 2023

https://www.globenewswire.com/news-release/2022/08/18/2500761/0/en/Innovative-Cellular-Therapeutics-ICT-Announces-First-Patient-Enrolled-for-the-Company-s-Phase-I-Trial-of-GCC19CART-for-Relapsed-Refractory-Metastatic-Colorectal-Cancer.html

GLOBENEWSWIRE
18 Aug 2022
ICT Announces Presentation at 2022 ASCO
ICT Announces Presentation at 2022 ASCO

26 May 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/05/26/2451216/0/en/Innovative-Cellular-Therapeutics-ICT-Announces-Presentation-at-2022-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html

GLOBENEWSWIRE
26 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty